Cardiovascular Critical Care I
Lopes RD, Heizer G, Aronson R, et al. Antithrombotic
therapy after acute coronary syndrome or PCI in atrial
fibrillation. N Engl J Med. 2019;380(16):1509-1524.
https://doi.org/10.1056/nejmoa1817083
Mathew R, Di Santo P, Jung RG, et al. Milrinone as com-
pared with dobutamine in the treatment of cardiogenic
shock. N Engl J Med. 2021;385(6):516-525. https://doi.
org/10.1056/nejmoa2026845
Mauri L, Kereiakes DJ, Yeh RW, et al. Twelve or 30
months of dual antiplatelet therapy after drug-eluting
stents. N Engl J Med. 2014;371(23):2155-2166. https://
doi.org/10.1056/nejmoa1409312
McEvoy JW, Ibrahim K, Kickler TS, et al. Effect of
intravenous fentanyl on ticagrelor absorption and plate-
let inhibition among patients undergoing percutaneous
coronary intervention: the PACIFY randomized clinical
trial (Platelet Aggregation with Ticagrelor Inhibition and
Fentanyl). Circulation. 2018;137(3):307-309. https://doi.
org/10.1161/circulationaha.117.031678
Mebazaa A, Pitsis AA, Rudiger A, et al. Clinical review:
practical recommendations on the management of peri-
2010;14(2):201. https://doi.org/10.1186/cc8153
Meek S, Morris F. ABC of clinical electrocardiography.
Introduction. I-Leads, rate, rhythm, and cardiac axis.
BMJ. 2002;324(7334):415-418. https://doi.org/10.1136/
bmj.324.7334.415
Meine TJ, Roe MT, Chen AY, et al. Association of
intravenous morphine use and outcomes in acute coro-
nary syndromes: results from the CRUSADE Quality
Improvement Initiative. Am Heart J. 2005;149(6):1043-
1049. https://doi.org/10.1016/j.ahj.2005.02.010
Møller JE, Engstrøm T, Jensen LO, et al. Microaxial
flow pump or standard care in infarct-related cardio-
genic shock. N Engl J Med. 2024;390(15):1382-1393.
https://doi.org/10.1056/nejmoa2312572
Montalescot G, van ’t Hof AW, Lapostolle F, et al.
Prehospital ticagrelor in ST-segment elevation myocar-
dial infarction. N Engl J Med. 2014;371(11):1016-1027.
https://doi.org/10.1056/nejmoa1407024
Moranville MP, Mieure KD, Santayana EM. Evaluation and
management of shock states: hypovolemic, distributive,
and cardiogenic shock. J Pharm Pract. 2011;24(1):44-
60. https://doi.org/10.1177/0897190010388150
Mullens W, Dauw J, Martens P, et al. Acetazolamide in
acute decompensated heart failure with volume over-
load. N Engl J Med. 2022;387(13):1185-1195. https://doi.
org/10.1056/nejmoa2203094
Nahumi N, Jorde U, Uriel N. Slope calculation for the
LVAD ramp test. J Am Coll Cardiol. 2013;62(22):2149-
2150. https://doi.org/10.1016/j.jacc.2013.05.098
Narang N, Chung B, Nguyen A, et al. Discordance
between clinical assessment and invasive hemody-
namics in patients with advanced heart failure. J Card
Fail.
2020;26(2):128-135.
https://doi.org/10.1016/j.
cardfail.2019.08.004
Notarangelo FM, Maglietta G, Bevilacqua P, et al.
Pharmacogenomic approach to selecting antiplatelet
therapy in patients with acute coronary syndromes: the
PHARMCLO trial. J Am Coll Cardiol. 2018;71(17):1869-
1877. https://doi.org/10.1016/j.jacc.2018.02.029
O’Gara PT, Kushner FG, Ascheim DD, et al. 2013
ACCF/AHA
guideline
for
the
management
of
ST-elevation myocardial infarction: a report of the
American College of Cardiology Foundation/American
Heart Association Task Force on Practice Guidelines.
Circulation.
2013;127(4):e362-e425.
https://doi.
org/10.1161/cir.0b013e3182742cf6
Ommen SR, Mital S, Burke MA, et al. 2020 AHA/ACC
guideline for the diagnosis and treatment of patients with
hypertrophic cardiomyopathy: a report of the American
College of Cardiology/American Heart Association
Joint Committee on Clinical Practice Guidelines.
Circulation.
2020;142(25):e558-e631.
https://doi.
org/10.1161/cir.0000000000000937
Ondrus T, Kanovsky J, Novotny T, Andrsova I, Spinar
J, Kala P. Right ventricular myocardial infarction:
from pathophysiology to prognosis. Exp Clin Cardiol.
2013;18(1):27-30.
Ortiz M, Martín A, Arribas F, et al. Randomized com-
parison of intravenous procainamide vs. intravenous
amiodarone for the acute treatment of tolerated wide
QRS tachycardia: the PROCAMIO study. Eur Heart J.
2017;38(17):1329-1335. https://doi.org/10.1093/eurheartj/
ehw230
Otto CM, Nishimura RA, Bonow RO, et al. 2020
ACC/AHA guideline for the management of patients
with valvular heart disease: a report of the American
College of Cardiology/American Heart Association
Joint Committee on Clinical Practice Guidelines.